Institutional Career Development Core
机构职业发展核心
基本信息
- 批准号:10398853
- 负责人:
- 金额:$ 136.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcademyAddressAdvisory CommitteesAppointmentAwardBudgetsClinicalClinical InvestigatorClinical ResearchCommunitiesCompetenceComplexCustomDevelopmentDiseaseDiverse WorkforceEnrollmentEnsureEnvironmentFacultyFellowshipFinancial SupportFoundationsFundingFutureGrantHealthIndividualIndustryInstitutesK-Series Research Career ProgramsLearningLinkLongevityMedicalMentored Clinical Scientist Development ProgramMentorsMentorshipMissionModelingNational Center for Advancing Translational SciencesPeer ReviewPerformancePositioning AttributeProcessProgram DevelopmentResearchResearch MethodologyResearch PersonnelResourcesRiskSECTM1 geneScienceSpecial PopulationTrainingTraining SupportTranslational ResearchUnited States National Institutes of HealthUniversitiesWorkbasecareercareer developmentcatalystcommunity buildingeducation researchfaculty mentorfaculty supporthuman diseaseimprovedinnovationmedical schoolsnext generationprogramsspellingsuccesstranslational scientist
项目摘要
I. INSTITUTIONAL CAREER DEVELOPMENT CORE – KL2 PROGRAM: ABSTRACT
The Harvard Catalyst (HC) KL2 Program is the cornerstone across Harvard University (HU) and its affiliated
academic health centers (AHCs) to train the future leaders in clinical and translational research. The KL2
program admits, by a highly competitive process, CT investigators who are within the first 3 years of their initial
faculty appointment at HU. Over the period of this award, to meet CTSA requirements and budget reductions,
the HC KL2 program will admit 14 awardees in year 1, 13 awardees in year 2, 10 awardees in year 3, and will
reach the 9 allowable slots by year 4.
Each KL2 awardee will be enrolled for a period of two years to allow him/her to acquire by the end of the award
period: 1) Subsequent peer-reviewed funding from the NIH or disease-specific foundation grants, and 2)
Further support and acknowledgement at their AHCs as CT investigators who are critical to the institutional
mission as documented by financial support and a clear track for promotion. These are the two key metrics of
success of the HC KL2 program. To accomplish this, the KL2 program will create a community for junior CT
investigators to enhance their transition to independence.
The KL2 Program proposes four specific aims: (Aim 1) Select, mentor, and train HC KL2 trainees, and provide
a supportive Harvard-wide environment that ensures their success, and develops and sustains a robust
community of junior CT research investigators; (Aim 2) Optimize and individually tailor a customized
educational program that supports the training of KL2 trainees so that they become independent, collaborative,
and team science-based investigators committed to combating the most complex human diseases and health
problems; (Aim 3) Evaluate and continuously improve individual and team mentorship models that support
successful development and career progression of diverse HC KL2 trainees; and (Aim 4) Ensure that metrics
of success are continually used to identify and improve components of the program that most effectively
support career progression and transition of KL2 awardees to independence. These aims will be completed
with the contributions of outstanding faculty mentors, HC Cores that enhance education and research
methodology, and innovative HC programs that encourage team science and ensure a diverse workforce. KL2
graduates will become fully independent CT investigators capable of addressing unmet medical needs, and in
turn, training the next generation of CT investigators.
I.机构职业发展核心-KL 2课程:摘要
哈佛催化剂(HC)KL 2计划是哈佛大学(HU)及其附属机构的基石。
学术健康中心(AHCs),培养未来的临床和转化研究的领导者。KL2
该计划承认,通过一个高度竞争的过程,CT调查人员谁是在第一个3年内,他们的初步
在胡教授的任命。在此期间,为了满足CTSA的要求和预算削减,
HC KL 2计划将在第一年录取14名获奖者,第二年录取13名获奖者,第三年录取10名获奖者,并将
到第4年达到9个允许的插槽。
每名KL 2获奖者将注册两年,以便他/她在奖项结束时获得
期间:1)随后来自NIH或疾病特定基金会赠款的同行评审资金,以及2)
作为对机构至关重要的CT调查员,他们的AHC进一步支持和认可
使命,由财政支持和明确的晋升轨道记录。这是两个关键指标,
HC KL 2计划的成功。为了实现这一目标,KL 2计划将为初级CT创建一个社区
调查人员加强向独立性的过渡。
KL 2计划提出了四个具体目标:(目标1)选择,指导和培训HC KL 2学员,并提供
一个支持性的哈佛全环境,确保他们的成功,发展和维持一个强大的
初级CT研究者社区;(目标2)优化和个性化定制
支持KL 2学员培训的教育计划,使他们成为独立,协作,
和团队科学为基础的研究人员致力于打击最复杂的人类疾病和健康
(目标3)评估并持续改进个人和团队指导模式,
不同HC KL 2学员的成功发展和职业发展;以及(目标4)确保
持续地使用成功的评估来识别和改进计划中最有效的组件,
支持职业发展和KL 2获奖者向独立过渡。这些目标将得以实现
与杰出的教师导师的贡献,HC核心,提高教育和研究
方法和创新的人力资源计划,鼓励团队科学和确保多元化的劳动力。KL2
毕业生将成为完全独立的CT调查员,能够解决未满足的医疗需求,
反过来,培训下一代CT研究人员。
项目成果
期刊论文数量(31)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Association of Teaching Status and Mortality After Cancer Surgery.
- DOI:10.1097/as9.0000000000000073
- 发表时间:2021-09
- 期刊:
- 影响因子:0
- 作者:Lam MB;Riley K;Mehtsun W;Phelan J;Orav EJ;Jha AK;Burke LG
- 通讯作者:Burke LG
Patterns of Recording Epileptic Spasms in an Electronic Seizure Diary Compared With Video-EEG and Historical Cohorts.
- DOI:10.1016/j.pediatrneurol.2021.04.008
- 发表时间:2021-09
- 期刊:
- 影响因子:3.8
- 作者:LaGrant, Brian;Goldenholz, Daniel M.;Braun, Marvin;Moss, Robert E.;Grinspan, Zachary M.
- 通讯作者:Grinspan, Zachary M.
Focal Cooling for Drug-Resistant Epilepsy: A Review.
- DOI:10.1001/jamaneurol.2022.1936
- 发表时间:2022-09-01
- 期刊:
- 影响因子:29
- 作者:Niesvizky-Kogan, Itamar;Bass, Michelle;Goldenholz, Shira R.;Goldenholz, Daniel M.
- 通讯作者:Goldenholz, Daniel M.
Prolonged fasting drives a program of metabolic inflammation in human adipose tissue.
- DOI:10.1016/j.molmet.2020.101082
- 发表时间:2020-12
- 期刊:
- 影响因子:8.1
- 作者:Fazeli PK;Zhang Y;O'Keefe J;Pesaresi T;Lun M;Lawney B;Steinhauser ML
- 通讯作者:Steinhauser ML
Health Care Provider Perceptions of Caring for Individuals with Inherited Pancreatic Cancer Risk.
医疗保健提供者对照顾患有遗传性胰腺癌风险的个体的看法。
- DOI:10.1007/s13187-019-01623-1
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Underhill,MeghanL;Pozzar,Rachel;Chung,Daniel;Sawhney,Mandeep;Yurgelun,Mathew
- 通讯作者:Yurgelun,Mathew
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Miriam Antoinette Bredella其他文献
Miriam Antoinette Bredella的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Miriam Antoinette Bredella', 18)}}的其他基金
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
雌激素治疗绝经后妇女 NASH
- 批准号:
10307423 - 财政年份:2021
- 资助金额:
$ 136.37万 - 项目类别:
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
雌激素治疗绝经后妇女 NASH
- 批准号:
10618224 - 财政年份:2021
- 资助金额:
$ 136.37万 - 项目类别:
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
雌激素治疗绝经后妇女 NASH
- 批准号:
10445293 - 财政年份:2021
- 资助金额:
$ 136.37万 - 项目类别:
Oxytocin as a Neuroendocrine Therapy for Obesity in Youth
催产素作为青少年肥胖症的神经内分泌疗法
- 批准号:
10264930 - 财政年份:2020
- 资助金额:
$ 136.37万 - 项目类别:
Oxytocin as a Neuroendocrine Therapy for Obesity in Youth
催产素作为青少年肥胖症的神经内分泌疗法
- 批准号:
10118294 - 财政年份:2020
- 资助金额:
$ 136.37万 - 项目类别:
Oxytocin as a Neuroendocrine Therapy for Obesity in Youth
催产素作为青少年肥胖症的神经内分泌疗法
- 批准号:
10435539 - 财政年份:2020
- 资助金额:
$ 136.37万 - 项目类别:
Bone Metabolism in Adolescents Undergoing Bariatric Surgery
接受减肥手术的青少年的骨代谢
- 批准号:
9897530 - 财政年份:2017
- 资助金额:
$ 136.37万 - 项目类别:
Bone Metabolism in Adolescents UndergoingBariatric Surgery
接受减肥手术的青少年的骨代谢
- 批准号:
10115703 - 财政年份:2017
- 资助金额:
$ 136.37万 - 项目类别:
Bone Metabolism in Adolescents Undergoing Bariatric Surgery
接受减肥手术的青少年的骨代谢
- 批准号:
9301775 - 财政年份:2017
- 资助金额:
$ 136.37万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 136.37万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 136.37万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 136.37万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 136.37万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 136.37万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 136.37万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 136.37万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 136.37万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 136.37万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 136.37万 - 项目类别:
Research Grant














{{item.name}}会员




